Tumor ploidy as a major prognostic factor in advanced ovarian cancer

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Cancer

• Publication date

  1987-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19870115)59:2<317::AID-CNCR2820590225>3.0.CO;2-4PMID 3802018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemotherapy in advanced ovarian cancer

  2004cited by this paper
• Common epithelial cancer of the ovary.

  1985cited by this paper
• Adverse metabolic consequences of total parenteral nutrition

  1985cited by this paper
• Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.

  1985cited by this paper
• DNA content in renal cell carcinoma with reference to tumor heterogeneity

  1985cited by this paper
• Advanced ovarian carcinoma. Factors influencing survival

  1985cited by this paper
• Medical progress: common epithelial cancer of the ovary (second of two parts)

  1985cited by this paper
• Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma.

  1985cited by this paper
• Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

  1984cited by this paper
• Clinical and biological significance of aneuploidy in human tumours.

  1984cited by this paper
• Chemotherapy of ovarian cancer.

  1984cited by this paper
• Cellular DNA content--a stable feature in epithelial ovarian cancer.

  1984cited by this paper
• Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.

  1984cited by this paper
• Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.

  1984cited by this paper
• Influence of cellular DNA content on survival in advanced ovarian cancer.

  1984cited by this paper
• Prognostic significance of nuclear DNA content in serous ovarian tumors.

  1984cited by this paper
• Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

  1983cited by this paper
• Importance of Histologic Grading in the Prognosis of Epithelial Ovarian Carcinoma

  1982cited by this paper
• Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.

  1982cited by this paper
• Pathology of the Female Genital Tract

  1982cited by this paper
• Chemotherapy of ovarian cancer.

  1978cited by this paper
• Primary Epithelial Tumors of the Ovary

  1977cited by this paper
• Epithelial carcinoma of the ovary:prognostic importance of histologic grade.

  1975cited by this paper
• Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.

  1975cited by this paper
• FENFLURAMINE AND DREAMING

  1974cited by this paper
• The clinical evaluation of chemotherapeutic agents in cancer

  1949cited by this paper

• Chromosome Instability; Implications in Cancer Development, Progression, and Clinical Outcomes

  2020cites this paper
• The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity

  2019cites this paper
• Title: Evaluation of DNA Ploidy with Intraoperative Flow Cytometry may Predict Long-term Survival of Patients with Supratentorial Low-grade Gliomas: Analysis of 102 Cases

  2018cites this paper
• Evaluation of DNA ploidy with intraoperative flow cytometry may predict long-term survival of patients with supratentorial low-grade gliomas: Analysis of 102 cases.

  2018cites this paper
• MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis, and potentiates antineoplastic effect of cisplatin in ovarian cancer

  2016cites this paper
• MIB- 1 in Advance d Ovaria n Cance r Usin g Quantitativ e Imag e Analysi s

  2016cites this paper
• Application of Laser Scanning Cytometry to Clinical and Laboratory Hematology

  2011cites this paper
• SIGNIFICANCE OF DNA PLOIDY PATTERN IN DIAGNOSIS OF OVARIAN TUMOR

  2011cites this paper
• Flow cytometric analysis of nuclear DNA content in oral squamous cell carcinomas

  2011cites this paper
• CHAPTER 39 – Ovaries

  2009cites this paper
• Clinical Value of Morphometric and DNA Flow Cytometric Variables as Independent Predictors of Survival in Epithelial Ovarian Carcinoma: A 5-year Follow-up Study

  2009cites this paper
• Análise morfométrica de micronúcleos e colágeno intersticial em tumores de mama

  2008cites this paper
• Image analysis of DNA content and nuclear morphometry for predicting radiosensitivity of nasopharyngeal carcinoma.

  2008cites this paper
• DNA ploidy and cell cycle analyses in the bone marrow cells of patients with megaloblastic anemia using laser scanning cytometry

  2008cites this paper
• Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection

  2008cites this paper
• Ploidy in gynaecological cancers

  2005cites this paper
• DNA ploidy and cell-cycle analysis in pancreatic and ampullary carcinoma: flow cytometric study of formalin-fixed paraffin-embedded tissue

  2005cites this paper
• Reflectance-based optical diagnosis of epithelial pre-cancer: modeling spectroscopic measurements, fiber-optic probe design considerations, and analysis of tissue micro-optical properties

  2005cites this paper
• Prognostic significance of DNA ploidy in mucoepidermoid carcinoma

  2004cites this paper
• The immunology of colorectal cancer.

  2004cites this paper
• Light scattering from normal and dysplastic cervical cells at different epithelial depths: finite-difference time-domain modeling with a perfectly matched layer boundary condition.

  2003cites this paper
• Thinlayer法とLaser Scanning Cytometerを用いた卵巣上皮性・間質性腫瘍の細胞学的検討

  2003cites this paper
• Type I and type III collagen metabolites and peritoneal cells in predicting the clinical outcome of epithelial ovarian cancer patients

  2003cites this paper
• Immunology for Surgeons

  2002cites this paper
• Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer.

  2002cites this paper
• Flowzytometrische und immunhistochemische Untersuchungen zur Bestimmung der Tumorheterogenität beim Ovarialkarzinom

  2002cites this paper
• Flow cytometry of human solid tumours: clinical and research applications

  2002cites this paper
• Are DNA Ploidy and Epidermal Growth Factor Receptor Prognostic Factors for Untreated Ovarian Cancer?: A Prospective Study

  2001cites this paper
• Thymidine labeling index in epithelial ovarian cancer

  2001cites this paper
• Effect of Cellular DNA Content on the Prognosis of Epithelial Ovarian Cancers

  2001cites this paper
• Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms

  2000cites this paper
• Development of a syngeneic mouse model for events related to ovarian cancer.

  2000cites this paper
• Androgen receptor gene mutations do not occur in ovarian cancer.

  2000cites this paper
• Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.

  1999cites this paper
• Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.

  1999cites this paper
• Assessment of DNA content in formalin‐fixed, paraffin‐embedded tissue of lung cancer by laser scanning cytometer

  1999cites this paper
• Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.

  1998cites this paper
• Prognostic factors in ovarian cancer.

  1998cites this paper
• Borderline Tumors of the Ovary: A Clinico‐Pathologic and Immunohistochemical Study of 54 Cases

  1998cites this paper
• The clinical predictivity of biomarkers of stage III‐IV epithelial ovarian cancer in a prospective randomized treatment protocol

  1998cites this paper
• Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial ovarian cancer.

  1998cites this paper
• Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

  1998cites this paper
• Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of the ovary.

  1998cites this paper
• Clinical tumour markers in ovarian cancer.

  1998cites this paper
• Advances in the pathology of gynecologic cancer.

  1998cites this paper
• Nuclear DNA in histological and cytological specimens: measurement and prognostic significance.

  1997cites this paper
• Thymidine labeling index in colorectal carcinoma: relation to clinicopathological parameters and to mitotic index.

  1997cites this paper
• Clinical value of new techniques of gynecological tumor assessment

  1997cites this paper
• Prognostic factors in advanced ovarian cancer

  1997cites this paper
• Prognostic value of MIB‐1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis

  1997cites this paper
• Long‐term survival and DNA ploidy in advanced epithelial ovarian cancer

  1997cites this paper
• Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.

  1996cites this paper
• Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.

  1996cites this paper
• The Analysis of Drug-Induced Cell Cycle Perturbations by Flow Cytometry

  1996cites this paper
• Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival.

  1996cites this paper
• DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis.

  1996cites this paper
• DNA ploidy and MYC DNA amplification in ovarian carcinomas

  1996cites this paper
• DNA index reflects the biological behavior of ovarian carcinoma stage I-IIa.

  1996cites this paper
• Brief report: Prognostic importance of cellular DNA content in T1‐2 N0 laryngeal squamous cell carcinomas treated with radiotherapy

  1995cites this paper
• The influence of combination chemotherapy on antigen expression in ovarian cancer.

  1995cites this paper
• Tumor Heterogeneity and Immunotherapy of Cancer

  1995cites this paper
• Prospective randomized trials on cytoreduction in ovarian cancer.

  1995cites this paper
• Clinicopathologic Variables, Operative Characteristics, and DNA Ploidy in Predicting Outcome in Ovarian Epithelial Carcinoma

  1995cites this paper
• An evaluation of prognostic factors in advanced ovarian cancer.

  1995cites this paper
• Adenoid cystic carcinoma: Significance of DNA ploidy

  1995cites this paper
• Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.

  1995cites this paper
• Prognostic value of DNA ploidy as assessed with flow cytometry in uveal melanoma.

  1995cites this paper
• Flow cytometric DNA ploidy and S‐phase heterogeneity in advanced ovarian carcinoma

  1994cites this paper
• Prognostic significance of cell DNA content in early‐stage ovarian cancer (figo stages I and II/A) by means of automatic image cytometry

  1994cites this paper
• Surface Epithelial—Stromal Tumors of the Ovary

  1994cites this paper
• Tumor cell-selective flow cytometric analysis for DNA content and cytokeratin expression of clinical tumor specimens by "cross-gating".

  1994cites this paper
• Flow cytometric analysis of uterine sarcomas.

  1994cites this paper
• Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis.

  1994cites this paper
• Cellular DNA content and survival in advanced ovarian carcinoma

  1994cites this paper
• Near-diploid transitional cell carcinoma: A preliminary report

  1994cites this paper
• Evaluation of deoxyribonucleic acid ploidy and S‐phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: A prospective study

  1994cites this paper
• Thymidylate synthase activity as a prognostic factor in ovarian cancer.

  1994cites this paper
• Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: A prospective study

  1994cites this paper
• Advances in flow cytometry for diagnostic pathology.

  1994cites this paper
• Evaluation of DNA ploidy in endometrial cancer.

  1993cites this paper
• Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary

  1993cites this paper
• Prognostic markers in epithelial ovarian cancer.

  1993cites this paper
• DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary

  1993cites this paper
• Clinical and prognostic features of advanced ovarian carcinoma.

  1993cites this paper
• Quantitative pathologic features as predictors of long-term survival in patients with advanced ovarian cancer treated with cisplatin

  1993cites this paper
• DNA Content and Tumor Response to Induction Chemotherapy in Patients with Advanced Laryngeal Squamous Cell Carcinoma

  1993cites this paper
• Determination of proliferation index in advanced ovarian cancer using quantitative image analysis.

  1993cites this paper
• The role of DNA index as a prognostic factor in early cervical carcinoma.

  1993cites this paper
• High levels of DNA index heterogeneity in advanced breast carcinomas. Evidence for DNA ploidy differences between lymphatic and hematogenous metastases

  1993cites this paper
• Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma.

  1993cites this paper
• Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.

  1993cites this paper
• Advanced ovarian cancer. An overview of multi-variate analyses of prognostic variables with special reference to the role of cytoreductive surgery.

  1993cites this paper
• The prognostic value of nuclear roundness and neopterin in ovarian cancer.

  1993cites this paper
• Flow cytometric evaluation of ovarian cancer

  1993cites this paper
• Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy

  1993cites this paper
• Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.

  1993cites this paper
• Prognostic factors in well‐differentiated early‐stage epithelial ovarian cancer

  1993cites this paper
• DNA flow cytometric analysis of serous ovarian tumors of low malignant potential

  1993cites this paper
• p53 accumulation in ovarian carcinomas and its prognostic implications.

  1993cites this paper
• Cellular DNA Content as a New Prognostic Tool in Patients with Borderline Tumors of the Ovary. A Second Look

  1993cites this paper